Volume 11, Issue 3 (11-1997)                   Med J Islam Repub Iran 1997 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
KHALILI M A, VAHIDI S, AFLATOUNIAN A, KARIMZADEH M A, AMIR-ARJMAND H. INTRACYTOPLASMIC SPERM INJECTION FOR THE TRE ATMENT OF MALE FA CTOR INFERTILITY-THE FIRST PRELIMINA RY REPORT FROM IRAN. Med J Islam Repub Iran 1997; 11 (3) :181-185
URL: http://mjiri.iums.ac.ir/article-1-1088-en.html
INTRACYTOPLASMIC SPERM INJECTION FOR THE TRE ATMENT OF MALE FA CTOR INFERTILITY-THE FIRST PRELIMINA RY REPORT FROM IRAN
MOHAMMAD A. KHALILI , SERAJEDDIN VAHIDI , ABBAS AFLATOUNIAN , MOHAMMAD A. KARIMZADEH , HUSSAIN AMIR-ARJMAND
From the Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bou-Ali Avenue, Yazd,l.R. Iran.
Abstract:   (4307 Views)
The latest micromanipulative technique, intracytoplasmic sperm injection (ICSI), has been very successful in cases of severe male factor infertility. The main objective of this study is to report the results of our fIrst experience with ICSI in cases of male factor infertility, as well as patients who had failed their previous cycles with conventional in vitro fertilization (IVF). Normal fertilization occurred in 30.9% of oocytes retrieved from 99 patients. Embryo transfer was done for 67.7% of the patients, and a total of 12 (12.12%) clinical pregnancies were achieved. The success rate was noticeably lower in patients greater than 35 years old, and in patients with severely abnormal sperm parameters (e.g., oligoasthenoteratozoospermia). This study suggests that ICSI is a method of choice to treat couples with severe male factor infertility. Patients' age, as well as sperm parameters, can affect the success rate of infertility treatment with ICSI.
Keywords: Infertility, IVF
Full-Text [PDF 436 kb]   (1603 Downloads)    
Type of Study: Original Research | Subject: Internal Medicine
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.